Intracerebral metastases natural history, complications and prognosis

Intracerebral metastases Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Intracerebral Metastases from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Intracerebral metastases natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Intracerebral metastases natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Intracerebral metastases natural history, complications and prognosis
CDC on Intracerebral metastases natural history, complications and prognosis
Intracerebral metastases natural history, complications and prognosis in the news
Blogs on Intracerebral metastases natural history, complications and prognosis
Directions to Hospitals Treating Intracerebral metastases
Risk calculators and risk factors for Intracerebral metastases natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Prognosis

• Depending on the type of primary cancer, the age of the patient, the absence or presence of extracranial metastases, and the number of metastatic sites in the brain at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor.
• The median survival time of all patients with intracerebral metastases is 2.3 months.
• However, in some patients such as those with no extracranial metastases, those who are younger than 65 years, and those with a single site of metastasis in the brain only, the prognosis is much better with the median survival rate of up to 13.5 months.

References

Template:WikiDoc Sources